Evidence map›Paper›PMID 36816393›Full record

ArticleContemporary oncology (Poznan, Poland)2022

Toluidine blue for the detection of sentinel lymph nodes in patients with thyroid cancer.

Yuliia Moskalenko, Andrii Kurochkin, Ihor Vynnychenko, Oleksandr Kravets, Artem Piddubnyi, Roman Moskalenko, Oleksandr Potapov

Open access · goldAbstract read
In one paragraph

Article in Contemporary oncology (Poznan, Poland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuliia MoskalenkoDepartment of Oncology and Radiology, Sumy State University, Sumy, Ukraine.
Andrii KurochkinDepartment of Thoracic Surgery, Sumy Regional Council Municipal Non-Profit Enterprise «Sumy Regional Clinical Oncology Centre, Sumy, Ukraine.
Ihor VynnychenkoDepartment of Oncology and Radiology, Sumy State University, Sumy, Ukraine.
Oleksandr KravetsDepartment of General Surgery, Sumy State University, Sumy, Ukraine.
Artem PiddubnyiDepartment of Pathology, Sumy State University, Sumy, Ukraine.
Roman MoskalenkoUkrainian-Swedish Research Centre SUMEYA, Sumy State University, Sumy, Ukraine.
Oleksandr PotapovDepartment of Neurosurgery, Sumy State University, Sumy, Ukraine.
Sumy State University · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Thyroid cancer (TC) demonstrates steady growth in incidence worldwide and remains an urgent problem in oncology. The detection of sentinel lymph nodes (SLN) with a selective dye and further histological examination in selecting the proper (personalized) surgical strategy and the volume of surgical intervention for clinically undetermined regional lymph nodes. The purpose of the study is to evaluate the effectiveness and safety of intraoperative detection of SLN with a 1% toluidine blue aqueous solution. Material and methods: The significant tasks are to identify the pattern of TC metastases to cervical lymph nodes, to establish the prevalence of "skip" metastases, to compare the frequency of complications after total thyroidectomy and central neck dissection and lateral neck dissection with total thyroidectomy and central neck dissection, and to determine the feasibility of the application of lateral neck dissections in patients with papillary and follicular TC without metastases to regional lymph nodes (according to physical examination and ultrasound). Results: According to our data the SLN identification rate was 97.6%. Sensitivity, specificity, positive predictive value, negative predictive value, and frequency of false negative and false positive results was 89.2, 94.6, 88.03, 95.16, 10.8, and 5.4%, respectively. The most common metastasis was in the central neck compartment (83.7%). Skip metastases were determined in 4.9% of patients. Conclusions: The low prevalence of "skip" metastases and a significant risk of postoperative complications (wound exudation, lymphorrhagia, inflammation, hypoparathyroidism, paresis of the vocal cords) support the idea that lateral neck dissection is appropriate only in cases of confirmed metastases by physical examination and/or ultrasound at the preoperative stage.

Indexed as

complicationsskip metastasisthyroid cancertoluidine blue

Identifiers

PMID36816393
PMCPMC9933357
OpenAlexW4318820911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.